Quarterly report pursuant to Section 13 or 15(d)

Stock-Based Compensation (Tables)

v3.24.1.u1
Stock-Based Compensation (Tables)
3 Months Ended
Mar. 31, 2024
Share-Based Payment Arrangement [Abstract]  
Schedule of Nonvested Restricted Stock Units Activity
A summary of RSU activity for the three months ended March 31, 2024 is as follows (in thousands, except per share data):
Number of Shares Weighted-Average Grant Date Fair Value Per Share Aggregate Intrinsic Value (in thousands)
Balances—December 31, 2023
31,076,699 $ 6.41  $ 206,660 
Granted 10,064,357 $ 6.07   
Vested (6,034,073) $ 6.28   
Forfeited (421,497) $ 6.01   
Balances—March 31, 2024
34,685,486 $ 6.34  $ 185,914 
Summary of stock-based compensation expense
The following sets forth the total stock-based compensation expense for the Company's stock awards included in the Company’s condensed consolidated statements of operations (in thousands):
Three Months Ended March 31,
2024 2023
Research and development expenses $ 20,670  $ 13,044 
Selling, general and administrative expenses 6,347  4,214 
Total stock-based compensation expense $ 27,017  $ 17,258